Skip to main content
Top

International Journal of Hematology

Issue 2/2013

Content (21 Articles)

Images in Hematology

Atypical chronic myeloid leukemia harboring NUP98-HOXA9

Hiromichi Murayama, Hiromichi Matsushita, Kiyoshi Ando

Review Article

Generation of iPS cells from normal and malignant hematopoietic cells

Keiki Kumano, Shunya Arai, Mineo Kurokawa

Rapid Communication

NOTCH and NF-κB interplay in chronic lymphocytic leukemia is independent of genetic lesion

Stefano Baldoni, Paolo Sportoletti, Beatrice Del Papa, Patrizia Aureli, Erica Dorillo, Emanuela Rosati, Raffaella Ciurnelli, Pierfrancesco Marconi, Franca Falzetti, Mauro Di Ianni

Original Article

Endothelial activation and inflammation biomarkers in children and adolescents with sickle cell disease

Emmanuil S. Hatzipantelis, Zoe Dorothea Pana, N. Gombakis, A. Taparkou, V. Tzimouli, D. Kleta, D. J. Zafeiriou, V. Garipidou, F. Kanakoudi, M. Athanassiou

Original Article

A phase I/II study of ofatumumab (GSK1841157) in Japanese and Korean patients with relapsed or refractory B-cell chronic lymphocytic leukemia

Yoshiaki Ogawa, Michinori Ogura, Tatsuya Suzuki, Kiyoshi Ando, Toshiki Uchida, Yukari Shirasugi, Kensei Tobinai, Je Hwan Lee, Masazumi Kase, Koichi Katsura, Tomomitsu Hotta

Original Article

A retrospective clinical analysis of Japanese patients with peripheral T-cell lymphoma not otherwise specified: Hokkaido Hematology Study Group

Yoshihiro Torimoto, Kazuya Sato, Katsuya Ikuta, Toshiaki Hayashi, Yasuo Hirayama, Junki Inamura, Hajime Kobayashi, Ryoji Kobayashi, Kyuhei Koda, Mitsutoshi Kurosawa, Akio Mori, Shuichi Ota, Hajime Sakai, Akio Shigematsu, Motohiro Shindo, Hitoshi Shinzaki, Fumihiko Takahashi, Rishu Takimoto, Junji Tanaka, Satoshi Yamamoto, Yutaka Kohgo, Takashi Fukuhara

Original Article

Bortezomib, doxorubicin and intermediate-dose dexamethasone (iPAD) therapy for relapsed or refractory multiple myeloma: a multicenter phase 2 study

Yasushi Takamatsu, Kazutaka Sunami, Tsuyoshi Muta, Hiroaki Morimoto, Toshihiro Miyamoto, Masakazu Higuchi, Kimiharu Uozumi, Hiroyuki Hata, Kazuo Tamura

Original Article

Autologous peripheral blood stem cell transplantation with granulocyte colony-stimulating factor combined conditioning regimen as a postremission therapy for acute myelogenous leukemia in first complete remission

Tetsuya Eto, Ken Takase, Toshihiro Miyamoto, Yuju Ohno, Tomohiko Kamimura, Koji Nagafuji, Yasushi Takamatsu, Takanori Teshima, Hisashi Gondo, Shuichi Taniguchi, Koichi Akashi, Mine Harada

Original Article

Unrelated allogeneic bone marrow-derived mesenchymal stem cells for steroid-refractory acute graft-versus-host disease: a phase I/II study

Kazuo Muroi, Koichi Miyamura, Kazuteru Ohashi, Makoto Murata, Tetsuya Eto, Naoki Kobayashi, Shuichi Taniguchi, Masahiro Imamura, Kiyoshi Ando, Shunichi Kato, Takehiko Mori, Takanori Teshima, Masaki Mori, Keiya Ozawa

Original Article

Acute exacerbation of Toxoplasma gondii infection after hematopoietic stem cell transplantation: five case reports among 279 recipients

Masahiko Sumi, Fumie Aosai, Kazumi Norose, Wataru Takeda, Takehiko Kirihara, Keijiro Sato, Yuko Fujikawa, Ikuo Shimizu, Toshimitsu Ueki, Yuki Hirosima, Mayumi Ueno, Naoaki Ichikawa, Masahide Watanabe, Hikaru Kobayashi

Original Article

Feasibility of reduced-intensity conditioning followed by unrelated cord blood transplantation for primary hemophagocytic lymphohistiocytosis: a nationwide retrospective analysis in Japan

Akihisa Sawada, Shouichi Ohga, Eiichi Ishii, Masami Inoue, Keiko Okada, Jiro Inagaki, Hiroaki Goto, Nobuhiro Suzuki, Kazutoshi Koike, Yoshiko Atsuta, Ritsuro Suzuki, Hiromasa Yabe, Keisei Kawa, Koji Kato, Koji Yasutomo

Original Article

Micafungin for empirical antifungal therapy in patients with febrile neutropenia: multicenter phase 2 study

Hiroki Mizuno, Masashi Sawa, Masamitsu Yanada, Mizuho Shirahata, Masato Watanabe, Tomonori Kato, Hirokazu Nagai, Yukiyasu Ozawa, Takanobu Morishita, Motohiro Tsuzuki, Emi Goto, Akane Tsujimura, Ritsuro Suzuki, Yoshiko Atsuta, Nobuhiko Emi, Tomoki Naoe

Case Report

Successful treatment with rituximab of an infant with refractory autoimmune hemolytic anemia

Kunihiko Moriya, Tetsuro Matsuhashi, Masaei Onuma, Hidetaka Niizuma, Takeshi Rikiishi, Hiroshi Asada, Jun Suzuki, Yoji Sasahara, Shigeo Kure

Case Report

First reported case of compound heterozygosity for HbA2-Yialousa (HBD: c.82 G>C) and HbA2-Wrens (HBD: c.295 G>A) in Oman

Shoaib Al Zadjali, Wafa Bashir, David Gravell, Arwa Z. Al Riyami, Yasser Wali, Shahina Daar

Case Report

Unique association of Waldenström macroglobulinemia with optic neuritis and monoclonal T cell expansion

Ken Morita, Akihide Yoshimi, Akiko Masuda, Motoshi Ichikawa, Yutaka Yatomi, Mineo Kurokawa

Case Report

Angioimmunoblastic T-cell lymphoma with intramedullary production of platelet-derived growth factor and possibly complicating myelofibrosis: report of a case with review of the literature

Yasunobu Sekiguchi, Nana Matsuzawa, Asami Shimada, Hidenori Imai, Mutsumi Wakabayashi, Keiji Sugimoto, Noriko Nakamura, Tomohiro Sawada, Kouji Izutsu, Kengo Takeuchi, Yasunori Ohta, Norio Komatsu, Masaaki Noguchi

Case Report

Successful treatment of a patient with adult T cell leukemia/lymphoma using anti-CC chemokine receptor 4 monoclonal antibody mogamulizumab followed by allogeneic hematopoietic stem cell transplantation

Kenji Motohashi, Taisei Suzuki, Kumiko Kishimoto, Ayumi Numata, Yuki Nakajima, Takayoshi Tachibana, Rika Ohshima, Hideyuki Kuwabara, Masatsugu Tanaka, Naoto Tomita, Yoshiaki Ishigatsubo, Shin Fujisawa

Case Report

A case of Schizophyllum commune sinusitis following unrelated cord blood transplantation for acute lymphoblastic leukemia

Takashi Toya, Akihito Shinohara, Keita Tatsuno, Sachiko Seo, Yasuhito Nannya, Motoshi Ichikawa, Koichi Makimura, Kyoji Moriya, Mineo Kurokawa

Letter to the Editor

High early death rate in elderly patients with acute promyelocytic leukemia treated with all-trans retinoic acid combined chemotherapy

Jun Imagawa, Yuka Harada, Takeshi Shimomura, Hideo Tanaka, Yoshiko Okikawa, Hironori Harada

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine